June 2013

Genetically modified stem cells are effective against acute respiratory diseases

Leave a Comment / Genes, Disease and Therapy Program, Immune-inflammatory Processes and Gene Therapeutics, Translational Medicine Area / By

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Vall d’Hebron Research Institute (VHIR) have shown that administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury. Study results were published in the American Journal of Respiratory Cell and Molecular Biology. Acute lung injury […]

Genetically modified stem cells are effective against acute respiratory diseases Read More »

An epigenetic change causes the formation of spheres of DNA and proteins that block antitumor genes

Leave a Comment / Sin categorizar / By

Researchers observed that genes that protect from cancer as the vitamin A receptor alter its activity in colon cancer cells by the presence of spherical structures formed by DNA (in this case expression regulatory regions of genes) and proteins called histones. “We have observed,” said the researcher Manel Esteller, “that epigenetic drugs, capable of demethylating

An epigenetic change causes the formation of spheres of DNA and proteins that block antitumor genes Read More »

A group of professionals of the IDIBELL participates in the elaboration of the strategic plan of the institution for the coming years

Leave a Comment / Infectious disease and transplantation Program, Nephrology and renal transplantation, Neuropharmacology and pain , Neuroscience Area, Neuroscience Program, Translational Medicine Area / By

The IDIBELL is preparing the strategic plan, which will guide its actions over the next few years. This is a fundamental instrument in order to be able to articulate the actions the IDIBELL will develop over the coming years and which replaces the plan realized in 2007, valid till the end of 2012. This document

A group of professionals of the IDIBELL participates in the elaboration of the strategic plan of the institution for the coming years Read More »

A diabetes drug, a promising treatment for neurodegenerative disease

Leave a Comment / Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

Researchers of the IDIBELL have shown that a drug used to control Type II diabetes can help repair the spinal cords of mice suffering from the inherited disease adrenoleukodystrophy which, untreated, leads eventually to a paralysis, a vegetative state and death. This is an important step along the road to the development of a therapy

A diabetes drug, a promising treatment for neurodegenerative disease Read More »

We need to collaborate between different disciplines so that the benefit of music reverts on society

Leave a Comment / Cognition and Brain Plasticity, Neuroscience Area, Neuroscience Program / By

Bring together different researchers to promote a multidisciplinary debate focused on music with the aim to exchange opinions and to provide an information as complete as possible about its effects on the evolution of our species, as well as in the attitudes, emotions, and social behavior, has been the intention of the cycle “The music

We need to collaborate between different disciplines so that the benefit of music reverts on society Read More »

Identified a key protein in maintaining the identity of B lymphocytes

Leave a Comment / Cancer / By

Researchers of the Epigenetics and Cancer Biology Program at IDIBELL, led by researcher Maribel Parra, have identified a transcriptional repressor, histone deacetylase HDAC7, involved in the identity of B cells, the cells responsible to create antibodies in our immune system. The results of the study, published in PLoS Genetics, show that HDAC7 is expressed specifically

Identified a key protein in maintaining the identity of B lymphocytes Read More »

The use of more potent antithrombotic drugs is recommended in high-risk heart attack patients

Leave a Comment / Cardiovascular Diseases Research Group (BIO-HEART), Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Traslacional Medicine / By

The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code. The study concludes that when patients arrive

The use of more potent antithrombotic drugs is recommended in high-risk heart attack patients Read More »

Manel Esteller, Rey Jaime I Prize in basic research

Leave a Comment / Cancer / By

The director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor, Manel Esteller has been awarded with the Rey Jaime I Prize in basic research in its 25th edition. The Rey Jaime I Awards Foundation celebrates its 25th anniversary with the participation of

Manel Esteller, Rey Jaime I Prize in basic research Read More »

Scroll to Top